|
SGK196 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.175700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.999400E-03 |
| Normal-vs-Stage2 |
1.338410E-02 |
| Normal-vs-Stage3 |
1.353750E-02 |
| Normal-vs-Stage4 |
4.837400E-03 |
| Stage1-vs-Stage2 |
5.892400E-01 |
| Stage1-vs-Stage3 |
9.083200E-01 |
| Stage1-vs-Stage4 |
4.805000E-01 |
| Stage2-vs-Stage3 |
6.786200E-01 |
| Stage2-vs-Stage4 |
9.077000E-01 |
| Stage3-vs-Stage4 |
5.661600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.378900E-03 |
| Normal-vs-AfricanAmerican |
3.122200E-01 |
| Normal-vs-Asian |
6.677600E-03 |
| Caucasian-vs-AfricanAmerican |
4.343600E-01 |
| Caucasian-vs-Asian |
4.202200E-01 |
| AfricanAmerican-vs-Asian |
1.918840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06339999999838E-05 |
| Normal-vs-Female |
1.846400E-02 |
| Male-vs-Female |
1.023610E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.336200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.341800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.001700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.484200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.879000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.077800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.875000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.482200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.402000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.586200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.647000E-01 |
| Classical-VS-Follicular |
4.665600E-02 |
| Classical-VS-Other |
9.748200E-02 |
| Classical-VS-Normal |
2.417700E-02 |
| Tall-VS-Follicular |
4.180000E-01 |
| Tall-VS-Other |
1.497210E-01 |
| Tall-VS-Normal |
5.627800E-02 |
| Follicular-VS-Other |
2.745000E-01 |
| Follicular-VS-Normal |
5.433900E-04 |
| Other-VS-Normal |
1.066420E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.443600E-03 |
| Normal-vs-N1 |
3.440400E-03 |
| N0-vs-N1 |
4.994800E-01 |
|
|
